Medicare Enrolled
Dr. Cuong-Dung Do, M.D.
Ophthalmology · Westminster, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Do from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Do?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Do
Dr. Cuong-Dung Do is an ophthalmology specialist in Westminster, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Do performed 11,090 Medicare services across 9,204 unique beneficiaries.
Between the years covered by Open Payments, Dr. Do received a total of $25,177 from 36 pharmaceutical and/or device companies across 771 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Do is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 9% volume in CA
$25,177 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,090
Medicare services
Top 9% in CA for ophthalmology
9,204
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~584 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
2,460 | $79 | $130 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
1,653 | $110 | $150 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
1,174 | $31 | $120 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
1,115 | $24 | $65 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
784 | $55 | $115 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
652 | $32 | $135 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
650 | $35 | $125 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
335 | $129 | $175 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
268 | $37 | $150 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
216 | $99 | $600 |
| Bevacizumab injection, 10 mg Administration of a 10 mg dose of bevacizumab medication via injection. |
214 | $57 | $275 |
| Eyelash removal with forceps This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area. |
205 | $18 | $114 |
| CT scan of cornea A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye. |
193 | $31 | $55 |
| Tear duct plug insertion A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface. |
186 | $103 | $276 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
174 | $463 | $1,700 |
| Imaging of front third of eye Imaging of the front third of the eye. |
156 | $27 | $70 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
150 | $9 | $25 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
70 | $293 | $500 |
| Laser eye fluid drainage tract creation A laser procedure used to create drainage tracts in the iris to help fluid flow out of the eye. |
68 | $265 | $600 |
| Slit lamp examination of the eye This procedure uses a specialized microscope to examine the front portion of the eye. |
63 | $33 | $175 |
| Removal of foreign body from external eye This procedure involves the removal of a foreign object from the surface of the eye, specifically from the conjunctiva or sclera. |
58 | $39 | $289 |
| Cataract removal with artificial lens and drainage device insertion Surgical removal of the eye's natural lens followed by the insertion of an artificial lens and a drainage device into the front chamber of the eye. |
46 | $585 | $1,800 |
| Insertion of drug delivery implant into tear duct A small implant containing medication is placed into the tear duct of the eye to deliver drugs directly to the eye over time. |
45 | $14 | $150 |
| Complex cataract removal with lens implant A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision. |
30 | $636 | $1,800 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $106 | $135 |
| Laser repair to improve eye fluid flow A laser procedure used to enhance the drainage of fluid within the eye. |
25 | $215 | $650 |
| Laser destruction of lens tissue A procedure that uses a laser to destroy or remove tissue within the eye's lens. |
25 | $334 | $1,000 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
19 | $126 | $199 |
| Eyelid growth removal A procedure to remove a growth from the eyelid. |
14 | $254 | $450 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $54 | $120 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
25.0% medium
73.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,177
Total received (2018-2024)
Avg $3,597/year across 7 years
Top 9% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
771
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,349 (64.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,828 (35.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,222
2023
$3,619
2022
$2,924
2021
$3,655
2020
$2,132
2019
$4,275
2018
$5,351
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb Americas Inc.
$1,005
Mallinckrodt Hospital Products Inc.
$348
Alcon Vision LLC
$339
Oyster Point Pharma, Inc.
$275
ABBVIE INC.
$266
Amgen Inc.
$245
ANI Pharmaceuticals, Inc.
$224
Tarsus Pharmaceuticals, Inc.
$159
SUN PHARMACEUTICAL INDUSTRIES INC.
$140
Johnson & Johnson Surgical Vision, Inc.
$135
Apellis Pharmaceuticals, Inc.
$33
Dompe US, Inc.
$30
Thea Pharma Inc.
$25
Top 3 companies account for 52.5% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan Inc.
$5,402
Eyevance Pharmaceuticals LLC
$2,662
Aerie Pharmaceuticals, Inc.
$2,289
Bausch & Lomb Americas Inc.
$1,783
Sun Pharmaceutical Industries Inc.
$1,501
Allergan, Inc.
$1,382
Oyster Point Pharma, Inc.
$1,323
Novartis Pharmaceuticals Corporation
$1,254
Alcon Vision LLC
$1,183
Mallinckrodt Hospital Products Inc.
$889
Bausch & Lomb, a division of Bausch Health US, LLC
$676
Johnson & Johnson Surgical Vision, Inc.
$572
Shire North American Group Inc
$496
ABBVIE INC.
$487
Kala Pharmaceuticals, Inc.
$403
AbbVie Inc.
$391
Horizon Therapeutics plc
$340
ANI Pharmaceuticals, Inc.
$287
Amgen Inc.
$245
TissueTech, Inc.
$188
Dompe US, Inc.
$174
Tarsus Pharmaceuticals, Inc.
$159
Sight Sciences, Inc.
$158
Ivantis, Inc
$152
SUN PHARMACEUTICAL INDUSTRIES INC.
$140
RxSight Inc
$136
EYEVANCE PHARMACEUTICALS LLC
$97
Ocular Therapeutix, Inc.
$89
Biogen, Inc.
$85
Apellis Pharmaceuticals, Inc.
$65
Thea Pharma Inc.
$48
Glaukos Corporation
$38
Akorn Operating Company LLC
$22
Akorn, Inc.
$20
Santen Inc.
$20
Carl Zeiss Meditec AG
$19
Top 3 companies account for 41.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · ALPHAGAN P · ALREX · AcrySof IQ PanOptix · BEPREVE · BESIVANCE · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · COMBIGAN · Catalys Laser System · Cequa · Clareon · DEXTENZA · DUREZOL · DURYSTA · ENVISTA · EYSUVIS · Flarex · Hydrus · INVELTYS · IYUZEH · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX · LOTEMAX SM · LUMIGAN · MIEBO · None Specified · OMNI · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · PAZEO · PROLENSA · PURIFIED CORTROPHIN GEL · Prokera · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · ReSTOR · Rhopressa · Rocklatan · SIMBRINZA · Simbrinza · Syfovre · TECNIS IOL · TEPEZZA · TRAVATAN Z · TYRVAYA · TearCare SmartLid · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Simplicity · TobraDex ST · Tobradex ST · VUITY · VYZULTA · Verkazia · XDEMVY · XEN · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · Zerviate · Zioptan · enVista MX60 IOL · iStent inject Trabecular Micro-Bypass System Model G2-M-IS · iStent inject W · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (65%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for ophthalmology in CA.
Geographic Context
Ophthalmologists within 10 mi
548
Per 100K population
17.3
County median income
$113,702
Nearest hospital
HUNTINGTON BEACH HOSPITAL
2.2 mi
2.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Do is a mixed practice specialist, with above-average Medicare volume (top 9% in CA), with low-engagement industry engagement in the top 9% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Do experienced with eye exam, established patient, focused?
Based on Medicare claims data, Dr. Do performed 2,460 eye exam, established patient, focused services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Do receive payments from pharmaceutical companies?
Yes. Dr. Do received a total of $25,177 from 36 companies across 771 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Do's costs compare to other ophthalmologists in Westminster?
Dr. Do's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Do) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Westminster
Browse ophthalmologists in Westminster ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in CA
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in CA
Which CA ophthalmologists receive the most from drug and device companies.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
By company
Eyevance Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Eyevance Pharmaceuticals LLC.
By company
Aerie Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Aerie Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology